Delivery Order SPE2DB20D9332-SPE2DB23FV3A2

Award Date 11/28/22
Potential Completion Date 12/19/22
Potential Value $9.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $30,948.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of Xolair 150 mg/ml syringes, a specialty pharmaceutical product, with a period of performance through June 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $6,189.60, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract provides for the delivery of Xolair 150 mg/ml syringes to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract between DMS Pharmaceutical Group and the DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,284.40 firm fixed-price contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $38,685.00, is for the supply of the pharmaceutical product Xolair 150 mg/ml syringe. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The IDC allows DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,137.60 contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/ml syringes, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which provides a wide range of...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a $1,547.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a period of performance through September 25, 2024, and is for the provision of the pharmaceutical product Xolair 150 mg/mL syringe. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $9,284.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/mL syringes and has a completion date of December 11, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
The U.S. Defense Logistics Agency (DLA) awarded a $7,737.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that supports the recurring pharmaceutical supply needs of military health facilities worldwide. Under this contract, DMS Pharmaceutical Group will provide the...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $30,948.00, is for the supply of Xolair 150 mg/mL syringes to support the medical supply needs of the Department of Defense (DoD). This delivery order was issued under a larger five-year, single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group...
  • SPE2DB20D9332
    Indefinite Delivery Contract
  • SPE2DB20D9332-SPE2DB23FV3A2
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $9,284.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/mL syringes and has an ultimate completion date of December 19, 2022. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This delivery order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group Inc. holds with the DLA, which enables the agency to order a comprehensive portfolio of pharmaceutical products to support the medical supply requirements of the Department of Defense.

Generated 2/27/25, 11:23 AM